A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds.

[1]  M. Amagai,et al.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. , 2009, The Journal of investigative dermatology.

[2]  Preety M. Sharma,et al.  Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. , 2009, The Journal of investigative dermatology.

[3]  M. Amagai,et al.  Decline of anti‐desmoglein 1 IgG ELISA scores by withdrawal of d‐penicillamine in drug‐induced pemphigus foliaceus , 2005, Clinical and experimental dermatology.

[4]  V. Aoki,et al.  The Role of Intramolecular Epitope Spreading in the Pathogenesis of Endemic Pemphigus Foliaceus (Fogo Selvagem) , 2003, The Journal of experimental medicine.

[5]  T. Nishikawa,et al.  Induction of Pemphigus Phenotype by a Mouse Monoclonal Antibody Against the Amino-Terminal Adhesive Interface of Desmoglein 3 1 , 2003, The Journal of Immunology.

[6]  W. Uter,et al.  Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles1 , 2003, The Journal of Immunology.

[7]  M. Davies,et al.  Carbamazepine‐induced pemphigus , 2003, Clinical and experimental dermatology.

[8]  J. Fairley,et al.  Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. , 2002, Clinical immunology.

[9]  M. Seishima,et al.  Increased antibody levels to desmogleins 1 and 3 after administration of carbamazepine , 2001, Clinical and experimental dermatology.

[10]  A. Ueki,et al.  Antidesmoglein Autoantibodies in Silicosis Patients with No Bullous Diseases , 2001, Dermatology.

[11]  R. Hoffmann,et al.  The Prevalence of Antibodies against Desmoglein 1 in Endemic Pemphigus Foliaceus in Brazil , 2000 .

[12]  Komai,et al.  Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus , 1999, The British journal of dermatology.

[13]  R. Wolf,et al.  Gaining more insight into the pathomechanisms of thiol-induced acantholysis. , 1997, Medical hypotheses.

[14]  S. Brenner,et al.  Penicillamine-induced bullous dermatoses. , 1996, Journal of the American Academy of Dermatology.

[15]  B. Dréno,et al.  Long-term interferon-alpha therapy induces autoantibodies against epidermis. , 1996, Dermatology.

[16]  N. Nagarwalla,et al.  Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  V. Ruocco,et al.  Pemphigus and Bullous Pemphigoid due to Drugs , 1991, International journal of dermatology.

[18]  J. Zone,et al.  Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. , 1991, The Journal of investigative dermatology.

[19]  D. Mutasim,et al.  Drug-induced pemphigus. , 1993, Dermatologic clinics.

[20]  A. Hood,et al.  Induction of acantholysis in organ explant culture by penicillamine and captopril. , 1989, Archives of dermatology.

[21]  V. Ruocco,et al.  Drug-induced pemphigus. , 1998, Clinics in dermatology.

[22]  K. Hashimoto,et al.  Penicillamine-induced pemphigus. Immunoglobulin from this patient induces plasminogen activator synthesis by human epidermal cells in culture: mechanism for acantholysis in pemphigus. , 1984, Archives of dermatology.

[23]  J. Zone,et al.  Penicillamine-induced pemphigus. , 1982, JAMA.

[24]  D. Silvers,et al.  Penicillamine-associated pemphigus: is it really pemphigus? , 1981, Journal of the American Academy of Dermatology.